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Abstract Children with an autism spectrum disorder
(ASD) and their unaffected siblings from 54 simplex (SPX,
one individual in the family affected) and 59 multiplex
(MPX, two or more individuals affected) families, and 124
controls were assessed on intelligence, social cognition and
executive functions. SPX and MPX ASD probands dis-
played similar cognitive profiles, but within-family con-
trasts were highest in SPX families, suggesting SPX-MPX
stratification may help parse etiological heterogeneity of
ASD. Unaffected siblings (regardless SPX or MPX) were
mostly unimpaired, suggesting that cognitive problems
may be part of the defining features of ASD, rather than
being an endophenotypic trait. Except for affective pro-
sody, which appeared to be the most sensitive cognitive
marker for detecting familial risk for ASD.
Keywords Autism Spectrum Disorder (ASD)  Simplex-
multiplex stratification  Family  Unaffected siblings 
Cognition
Introduction
Autism spectrum disorder (ASD) is a group of highly
heritable and severely impairing neurodevelopmental dis-
orders, characterized by impairments in social interaction
and communication, and restricted, stereotyped and repet-
itive behaviour (American Psychological Association
2013). ASD is the most heritable of all complex neu-
ropsychiatric conditions, with heritability estimates ranging
up to 90 % (Lichtenstein et al. 2010). ASD is marked by
substantial heterogeneity in symptom presentation, devel-
opmental course and etiologic mechanisms (Jones and Klin
2009). The genetics of ASD is complex with involvement
of both rare and common genetic variants. Rare genetic
variants predisposing to ASD are currently thought to
account for 10–20 % of all ASD cases (Betancur 2011).
They include rare mutations in genes which lead to
monogenic disorders that are frequently associated with
ASD, such as fragile X syndrome and tuberous sclerosis, as
well as mutations and copy number variations (CNVs,
these constitute deletions or duplications of larger frag-
ments of DNA often involving several genes) that may
contribute to (mono- and) oligogenic forms of ASD (Be-
tancur 2011 Persico and Napolioni 2013). Common vari-
ants, e.g. single nucleotide polymorphism (SNPs),
implicated in the etiology of ASD, on the other hand, are
assumed to each contribute a (very) small increase in dis-
ease risk (Wang et al. 2009). As ASD strongly reduces
reproductive fitness, it has been argued that part of the
genetic contribution to ASD is due to de novo mutations
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(Neale et al. 2012; D’Onofrio et al. 2014). In addition to
the strong genetic background, environmental influences,
gene 9 environment interaction, epigenetic factors, and
pre-perinatal complications also play an important role in
susceptibility to ASD (Gardener et al. 2009, 2011; Dietert
et al. 2011; Kinney et al. 2010; Wong et al. 2014). Multiple
causal pathways may thus underlie the same clinical pro-
files, and, at the same time, the complex etiology may
result in highly heterogeneous clinical profiles.
The heterogeneous character of ASD strongly hinders
research into etiology and effective treatment. An approach
to parse etiologic heterogeneity is to form more homoge-
neous subgroups of patients based on the familial occur-
rence of the disorder. Several studies have reported on the
genetic differences between families with only one indi-
vidual with ASD (the so-called single-incidence or simplex
[SPX] families) compared to families with two or more
affected individuals (multiple-incidence or multiplex
[MPX] families). These studies reported a more than
threefold rate of de novo mutations in SPX families
(*7–10 %), compared to MPX families (*2–3 %) or
control families (* 1 %) (Sebat et al. 2007; Marshall et al.
2008). In MPX families, shared genetic predispositions
based on a multifactorial etiology of common genes appear
to play a more important role (Freitag 2007), with members
of MPX families more often exhibiting ASD traits com-
pared to members of SPX families (Virkud et al. 2009;
Gerdts et al. 2013). We recently replicated the latter finding
in the sample described in the current study (Oerlemans
et al. 2015). These findings suggest that individuals from
SPX families are more likely than individuals from MPX
families to develop ASD as a result of sporadic genetic
and/or non-genetic causes strictly personal to the patient.
Assuming that SPX-MPX stratification identifies forms
of ASD with a different genetic architecture, we aimed to
study whether cognitive deficits differ between SPX and
MPX families, in probands and/or in unaffected siblings.
Previous studies in individuals with ASD have found defi-
cits in intelligence (typically strengths in performance IQ
(PIQ) over verbal IQ (VIQ)), social cognition (SC), exec-
utive functions (EF) and central coherence (CC) (Joseph
et al. 2002; Black et al. 2009; Happe and Ronald 2008;
Pellicano 2012). Direct comparisons of cognitive deficits
between individuals with SPX and MPX ASD are mostly
lacking thus far, and the vast majority of cognitive studies
have failed to clearly specify or adjust for simplex or
multiplex ascertainment process. So far, studies in SPX
ASD-only samples report a higher frequency of perfor-
mance[ verbal IQ discrepancy in cases compared to con-
trols (Ankenman et al. 2014), and an altered cortical shape
in brain regions that have been implicated in communica-
tion, higher order social processes (e.g. empathy and theory
of mind), spatial attention, visual processing and face
recognition (Dierker et al. 2013). Studies in MPXASD-only
samples report deficits in EF components such as planning
and set-shifting, theory of mind, and fluid and crystallized
intelligence (Nyde´n et al. 2011). To our knowledge, only
one study has examined the association of SPX versus MPX
status with cognitive functioning. Verbal and non-verbal IQ
and head circumference [HC; associated with impaired
brain connectivity and higher order abilities (Courchesne
and Pierce 2005)] were compared between children and
adolescents with autism from SPX and MPX families. The
authors reported that enlarged HC was related to social
deficits in SPX, but not MPX individuals, and that indi-
viduals with the lowest nonverbal IQ scores were mostly
classified SPX, whereas individuals with a higher than
average nonverbal IQ were mostly MPX (Davis et al. 2013).
These findings suggest that both SPX and MPX forms of
ASD are associated with a wide range of similar disabilities
in higher order cognitive processes, but that some cognitive
factors may be uniquely related to either SPX or MPX ASD
(e.g. lower IQ scores were reported for SPX ASD), and
more research is needed to clarify this issue.
Studies reporting on the presence of ASD-related cog-
nitive deficits in first-degree relatives are sparse and report
inconsistent findings (Oerlemans et al. 2014; Wong et al.
2006; Gokcen et al. 2009). A possible explanation for these
discrepant findings might be that these studies did not
differentiate between etiologically different (inherited
versus non-inherited) forms of ASD and thus might have
investigated relatives with and without familial loading as a
mixed group. A recent study using SPX-MPX stratification
to examine executive function of the parents of patients
with familial versus non-familial (sporadic) schizophrenia
confirmed this idea and reported that executive functions
were only impaired in parents with a family history of
schizophrenia (Erol et al. 2012). Of interest to us is whether
similar patterns can also be found in familial (MPX) versus
sporadic (SPX) ASD.
To test whether the cognitive architecture underlying
SPX and MPX autism families is different and useful for
parsing the etiological heterogeneity of ASD, the cognitive
performance of ASD probands and unaffected siblings
from SPX and MPX families was compared with each
other and with healthy controls. We selected cognitive
tasks that assess various cognitive domains previously
implicated in ASD (Gokcen et al. 2009; Eapen et al. 2013),
or have been described as promising cognitive endophe-
notypes for ASD in previous literature (Oerlemans et al.
2013; Oerlemans et al. 2014; Rommelse et al. 2011). We
hypothesized that potentially different forms of ASD might
result in dissimilar cognitive profiles in SPX and MPX
ASD probands, a finding with implications for treatment.
Further, we hypothesized that the within family contrast
between probands and unaffected siblings regarding
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cognitive aspects of the disorder was larger in SPX com-
pared to MPX families as indicated by (mild) cognitive
deficits (similar to their affected brother/sister) compared
to controls in unaffected siblings from MPX, but not SPX
families, a finding highly relevant to the identification of
cognitive endophenotypes for genetic research.
Method
Participants
ASD families were recruited as part of the large family-
genetic Biological Origins of Autism (BOA) study, (as
described previously in van Steijn et al. 2012). Case fam-
ilies were recruited through an outpatient clinic specialized
in ASD and ADHD pathology (Karakter Child and Ado-
lescent Psychiatry University Centre) and the Dutch Aut-
ism Association (NVA). Families potentially satisfying
inclusion criteria received an information brochure and, if
interested, were asked to return a pre-stamped response
card. Control families were recruited from the same geo-
graphical regions as the participating case families via
information leaflets. Inclusion criteria for all participants
were at least two biological siblings (in case families: at
least one child with a clinical diagnosis of ASD [Autism,
Asperger’s Syndrome (AS) or PDD-NOS (APA 2000);
diagnosis mostly based on Autism Diagnostic Interview-
Revised (ADI-R) and Autism Diagnostic Observation
Scale (ADOS) assessment]) and one biological parent
willing to participate, offspring age between 4 and
20 years, European Caucasian descent, and a IQ C 70, and
no diagnosis of epilepsy, brain disorders or known genetic
disorders, such as Down-syndrome or Fragile-X-syndrome
in order to reduce etiological heterogeneity and provide an
ASD sample with considerable clinical homogeneity.
Selected controls were required to have no formal or sus-
pected ASD.
Further, children were required to have an IQ C 70 for
two reasons. First, to ensure that the children were able to
perform the cognitive tasks selected in this study. One of
the difficulties that plague the literature in general and
hinders research in the low-functioning ASD group is that
comparable versions of tasks tapping relevant cognitive
domains that can be used in lower functioning individuals
are not available. Second, studies examining sporadic
genetic mutations in ASD have found that that significant
signals in ASD (e.g., excess of de novo loss of function
mutations, excess of genes with multiple functional de
novo mutations) are predominantly found in individuals
with ASD combined with low IQ or intellectual disability
(ID) (Robinson et al. 2014; Samocha et al. 2014). Robinson
and colleagues reported that de novo mutations are present
predominantly in male cases with low IQs, whereas boys
with ASD who have normal/high IQs have the same
number of de novo mutations as do individuals without
ASD. However, female cases had a higher frequency of
sporadic genetic events across the severity distribution (i.e.
both high and low IQs) (Robinson et al. 2014). Less is
known about the impact of sporadic mutations in children
with ASD with normal to above average IQs. Potentially,
the genetic architecture among ASDs varies as a function
of IQ. However, not everyone with a de novo mutation has
severe symptoms, indicating that one can have the same
high-risk genetic mutation in children with IQ[ 100 and
children on the low end of the IQ spectrum, but that the
mutations in the high-IQ individuals have more moderate
effects (Ronemus et al. 2014). The focus of our study was
to look at the role of sporadic versus common genetic
variants in high-functioning individuals with ASD.
Both the children already clinically diagnosed with
ASD, their siblings and their parents were carefully phe-
notyped for ASD using validated and standardized ques-
tionnaires and diagnostic interviews. For all children
scoring above clinical cut-off ([10 for the parent version or
[15 for the teacher version) on the social communication
questionnaire (SCQ) (Rutter et al. 2003), a formal diag-
nosis of ASD was made by a certified researcher using the
Autism Diagnostic Interview-Revised (ADI-R) (Le Cou-
teur et al. 2003 (Dutch version: De Jonge and De Bildt
2007). A lower cutoff was chosen for the parent reported
SCQ to avoid false negatives in their undiagnosed offspring
(van Steijn et al. 2012). Parents were screened with the
Autism Spectrum Quotient (AQ) (Baron-Cohen et al. 2001)
and the Adult Social Behavior Questionnaire (ASBQ)
(Horwitz et al. 2005). Parents scoring above clinical cut-off
were considered a suspected case (for more details, see
Oerlemans et al. 2014b). All instruments are validated
instruments for screening ASD (de Bildt et al. 2013;
Hoekstra et al. 2008; Rutter et al. 2003).
Families were then stratified into SPX and MPX based
on the number of affected individuals. SPX families were
required to have a single-affected proband, a minimum of
one male sibling and all siblings and parents of the proband
unaffected by ASD. Families were excluded if (a) only one
unaffected parent from a presumed SPX family based on
number of affected children participated in this study (to
minimize the risk of erroneous categorization because of
missing parental data) and (b) if the affected proband had
only female unaffected siblings [to account for higher
sibling recurrence risk in male siblings than female siblings
(Robinson et al. 2014; Ronemus et al. 2014)]. Families
with siblings and/or parents who displayed (sub) threshold
ASD symptoms, in addition to the proband, were catego-
rized as multiplex (MPX). A total of 54 SPX ASD pro-
bands (55.6 % firstborn), 77 SPX ASD unaffected siblings,
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91 MPX ASD probands (48.4 % firstborn), 46 MPX ASD
unaffected siblings, and 124 control children were included
in the current sample. SPX and MPX ASD families did not
differ from each other on family size and parental educa-
tional level, but had a larger family size and lower maternal
educational attainment than control families. Boys were
overrepresented in both proband groups and in SPX unaf-
fected siblings, but were underrepresented in MPX unaf-
fected siblings and controls. MPX unaffected siblings were
slightly older than other groups, see Table 1 for sample
characteristics and Supplement Table 1 for a full descrip-
tion of phenotyping and family classification (available
online).
Measures
Cognitive functioning was examined across a range of
domains. Verbal IQ (VIQ) was prorated by two subtests of
the Wechsler Intelligence Scale for Children or Wechsler
Adult Intelligence Scale, namely Similarities and Vocab-
ulary. Performance IQ (PIQ) was prorated by Block Design
and Picture Completion (Wechsler 2000, 2002). These
selected WISC-III subtests are known to correlate between
.90 and .95 with the Full-scale IQ (Groth-Marnat 1997).
Three social cognition tasks were administered: face
recognition, identification of facial emotions, and recog-
nition of affective prosody. Face recognition was measured
by asking children to identify a target face in a display set
that consisted of four faces. Identification of facial emo-
tions was measured by asking children to judge whether or
not the presented photograph of a human face showed one
of four target emotions (happiness, sadness, anger, fear).
To test the ability to recognize affective prosody, children
were instructed to listen through a headphone to (neutral)
spoken sentences that were spoken in a happy, sad, angry
or frightened manner and verbally identify the emotion in
the voice. Four executive function tasks were included:
response inhibition, visual and verbal working memory,
and set shifting. Response inhibition was measured with
the commonly used Go-NoGo paradigm where participants
were instructed to withhold a response when the NoGo
target was depicted. Visual and verbal working were
measured by instructing the participants to correctly
reproduce sequences of figures (visual) or digits (verbal)
that increased in difficulty after each succeeded trial. Set
shifting was measured by administering a task that required
a mixture of compatible and incompatible responses,
hypothesized to require a higher level of cognitive flexi-
bility. Cognitive tasks were selected from the Amsterdam
Neuropsychological Tasks (ANT) program, which is a
computer-aided assessment battery that allows for the
systematic evaluation of information processing capacities
and has been proven to be a sensitive and valid tool in
research into autism-related disorders. Test–retest reliabil-
ity and validity of the ANT-tasks are satisfactory and have
been described in De Sonneville (2005). Table 2 provides
an overview of the cognitive tasks used. For full task
descriptions, see Appendix 1 (available online) or else-
where (Oerlemans et al. 2013).
Procedure
Cognitive assessment of participants took place at Karakter
Child and Adolescent Psychiatry University Centre Nij-
megen and is described in more detail elsewhere (Oerle-
mans et al. 2013). If possible, stimulants were discontinued
for at least 24 h before testing and non-stimulants
according to guidelines to allow for sufficient wash-out.
Children were motivated with small breaks and received a
gift at the end of the session. Parents received a gift vou-
cher (minimum worth €20) and travel-related expenses
were covered. Additional data collected included blood or
saliva samples and behavioral data of all family members.
The study was approved by the local medical ethics board
and parents and children (12 years and older) signed for
informed consent. Children younger than 12 years of age
were asked to give their assent for participation.
Data analyses
Unlike the other tasks, the affective prosody recognition
task was not administered to children younger than 9 years
of age. The affective prosody recognition data was based
on 42 SPX probands, 70 MPX probands, 62 SPX unaf-
fected siblings, 34 MPX unaffected siblings and 79 con-
trols. The percentage of missing data was\5 % for the
majority of dependent measures. Exceptions were missing
values of 9.4 % for inhibition and 9.9 % for variability of
time estimation. Missings were replaced by means of
Expectation Maximization (Tabachnick and Fidell 2001).
Analyses were carried out with and without expectation
maximization, which revealed similar results and conclu-
sions. Results were therefore reported with missing data
replaced. To account for the influence of age and sex on
neuropsychological performance, we regressed scores for
each measure on age and sex and used the unstandardized
residuals as dependent variables. Most of the unstandard-
ized residuals were not normally distributed, therefore a
van der Waerden transformation was used to normalize the
dependent measures (Norusis 1992). This facilitated the
comparison between variables since variables were all
depicted on the same scale. Several of the dependent
variables were mirrored so that the z-scores of all measures
had the same meaning: lower z-scores indicated poorer
performance (e.g. more errors, slower and more variable
responses).
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Linear mixed models (LMM) were used to account for
the dependency in the data due to inclusion of siblings by
estimating a random intercept. Dependent variables were
the cognitive measures and group was the independent
variable. We contrasted specific groups of interest to
answer our research questions. First, two LMM analyses
Table 1 Sample characteristics
Controls (c) Simplex Multiplex Group contrasts ASD
versus controls
1. Probands 2. Unaffected
siblings
3. Probands 4. Unaffected
siblings
M (sd) M (sd) M (sd) M (sd) M (sd)
Number of childrena 124 54 77 91 46
Mean number of
children/family
2.3 2.7 2.8 SPX = MPX[ controls
Education fatherb 4.9 (1.1) 4.6 (1.1) 4.5 (0.8) SPX = MPX = controls
Education motherb 5.0 (0.9) 4.4 (0.9) 4.5 (0.8) SPX = MPX\ controls
Age 10.9 (3.6) 12.3 (3.5) 12.4 (3.6) 11.6 (3.4) 12.0 (3.7) 1 = 2 = 3 = c, 4[ c
Sex (% males) 41.9 85.2 72.7 71.4 41.3 1 = 2 = 3[ 4 = c
Mean estimated total
IQ (range)
107.9 (79–136) 100.7 (72–131) 106.6 (71–147) 100.6 (72–133) 104.4 (79–122) 1 = 2 = 3 = 4, 1 = 3\ c,
2[ 4, 2 = c, 4 = c
SCQ Total Score 3.0 (2.6) 17.9 (6.6) 3.2 (3.3) 19.6 (6.5) 6.2 (6.3) 1 = 3[ 4[ 2 = c
CSBQ ASD corec 2.6 (3.8) 26.2 (11.4) 5.4 (6.2) 27.5 (8.6) 11.5 (10.1) 1 = 3[ 4[ 2 = c
ASD autism spectrum disorders, SPX simplex, MPX multiplex, SCQ social communication questionnaire, CSBQ child social behavior ques-
tionnaire, c controls; 1 = SPX probands; 2 = MPX probands; 3 = SPX unaffected siblings; 4 = MPX unaffected siblings
a Affective prosody was not administered to children younger than 9 years of age and therefore based on 42 SPX probands, 70 MPX probands,
62 SPX unaffected siblings, 34 MPX unaffected siblings and 79 controls
b Education is the mean education level of fathers and mothers of probands and their unaffected siblings from SPX and MPX ASD families.
Educational attainment is rated on a 7-point scale: 1 = nursery school, 2 = primary education, 3 = secondary education first phase (high
school), 4 = secondary education, second phase, 5 = higher education first phase (bachelor), 6 = second education second phase (masters),
7 = higher education third phase (PhD)
c ASD core is an aggregate score of the CSBQ subscales reduced contact and social interests, difficulties in understanding social information,
stereotyped behaviour and fear of and resistance to changes
Table 2 Description of the neuropsychological tasks
Taska Measurement potential Dependent variables
Intelligence
Vocabulary, similarities, block design, picture
completion of WISC-III/WAIS-III
Estimated IQ VIQ and PIQ
Social cognition
Face recognition Face recognition Mean reaction time (ms)
Identification of facial emotions Identification of facial
emotional expressions
Mean reaction time (ms)
Prosody Affective prosody Mean reaction time (ms)
Executive function
GoNoGo Inhibition Percentage false alarms—percentage misses
Digit span Verbal working memory Max span backwards
Spatial temporal span Visuospatial working memory Percentage correct identified targets in correct
order (part backward)
Response organization objects Cognitive flexibility Percentage errors
WISC/WAIS-III Wechsler Intelligence Scale for Children or Wechsler Adult Intelligence Scale-III
a Details on each of the paradigms are provided elsewhere (Oerlemans et al. 2013)
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were run—separately for SPX and MPX ASD families-
with group defined as ASD probands versus ASD unaf-
fected siblings versus controls to examine whether cogni-
tive deficits were present in SPX and MPX probands and
MPX, but not SPX, unaffected siblings. Second, a LMM
with group defined as MPX versus SPX probands was run
to examine whether potentially different heritable forms of
ASD would result in (dis)similar cognitive profiles in ASD
patients. Last, a LMM with group defined as SPX versus
MPX ASD unaffected siblings to examine whether cogni-
tive performance of first-degree relatives was poorer in
MPX compared to SPX families. Furthermore, within
family discrepancy scores (estimated mean of proband
minus mean of unaffected sibling) in SPX versus MPX
families were compared to examine whether within family
contrast was higher in SPX than MPX families. A False
Discovery Rate (FDR) correction with a q-value setting of
0.05 was applied to control for multiple testing (Benjamini
2010). Given the unequal sample size for MPX and SPX
families, emphasis was given to effect sizes next to the
p values. Effect sizes (Cohen’s d) were calculated to define
small (d = .20), medium (d = .50), and large effects
(d = .80) (Cohen 1988). All analyses were carried out in
SPSS version 20.
Results
Cognitive measures sensitive to SPX-MPX
stratification
Comparing cognitive deficits in SPX and MPX ASD
probands
Testing our first hypothesis, we found that the cognitive
profiles of SPX and MPX probands were very similar. Both
SPX and MPX probands had significantly lower VIQ (SPX:
p\ .001, effect size in terms of Cohen’s d = .69; MPX:
p\ .001, d = .68) and PIQ (SPX: p = .008, d = .42;
MPX: p = .045, d = .28), and poorer face recognition
(SPX: p\ .001, d = .65; MPX: p = .004, d = .40),
affective prosody recognition (SPX: p\ .001, d = .92;
MPX: p\ .001, d = .70), and verbal working memory
(SPX: p = .003, d = .46; MPX: p = .031, d = .31) than
controls. However, the effects on PIQ and verbal working
memory in MPX (but not SPX) probands became non-
significant after FDR correction (q-values[ .10). Further,
SPX (but not MPX) probands differed significantly from
controls in the identification of facial emotions (SPX:
p = .010, d = .40; MPX: p = .097, d = .19), suggesting
that SPX forms of ASD makes patients more prone to
deficits in these domains, see Fig. 1 and Table 3.
Comparing unaffected siblings from SPX and MPX ASD
families
In agreement with our second hypothesis, we found that
unaffected siblings from MPX families had a significantly
lower VIQ (similar to their affected brother/sister) com-
pared to controls (siblings vs. controls: p\ .001, d = .57;
siblings vs. probands: p = .409, d = .12), whereas SPX
unaffected siblings were unimpaired in this domain
(p = .392, d = .13). SPX and MPX unaffected siblings
also differed significantly from each other on this measure
(p = .011, d = .47). Opposing our hypothesis, both SPX
and MPX unaffected siblings scored significantly worse
than controls, but similar to their affected brother or sister
on affective prosody (SPX: p\ .001, d = .65; MPX:
p = .002, d = .65), see Fig. 1. The unaffected siblings
from both SPX and MPX families did not differ from
controls on all other cognitive measures (SPX: all p values
[.27, all d values \.16; MPX: all p values [.25, all
d values\.20).
Comparing affected and unaffected siblings within SPX
and MPX ASD families
Comparing siblings within families revealed that affected
and unaffected siblings from MPX families resembled each
other more closely in cognitive functioning than affected-
unaffected siblings from SPX families. That is, in SPX
families, within-family discrepancy (proband-unaffected
sibling contrast) was larger for SPX than for MPX families
for VIQ (t = 2.56, p = .012) and identification of facial
cFig. 1 Comparing unaffected siblings from and within-family con-
trasts in SPX and MPX ASD families. Note. ASD autism spectrum
disorder, n.s. non significant. The interpolation lines represent the
mean z-score and the 95 % CI of normal controls. The error bars
represent the 95 % confidence interval (CI). Lower z-scores indicate
worse performance. Significant group differences (case groups versus
controls) that survived FDR correction are depicted using asterisks
(***p\ .001, **p\ .01). Within-family contrasts are depicted using
squiggly brackets. Within-family contrasts were higher in SPX
compared to MPX families for IQ, emotion recognition and visual
working memory, suggesting that affected and unaffected siblings
from MPX families resembled each other more closely in cognitive
functioning than affected-unaffected siblings from SPX families.
Unaffected siblings from both SPX and MPX families were unim-
paired on these cognitive domains (a–e). In line with our expecta-
tions, we found that MPX unaffected siblings had a significantly
lower VIQ (similar to their affected brother/sister) compared to
controls, whereas SPX unaffected siblings were unimpaired in this
domain. In addition, within-family contrast was highest in SPX ASD
families, but non-significant in MPX ASD families for VIQ (e). An
unexpected finding was that SPX (like MPX) unaffected siblings
differed significantly from controls (but not from their affected
brother/sister) on affective prosody (f)
494 J Autism Dev Disord (2016) 46:489–501
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emotions (t = 2.38, p = .019). SPX probands differed
significantly from their unaffected siblings on both mea-
sures (VIQ: p\ .001, d = .59; facial emotions: p = .002,
d = .50), whereas MPX unaffected siblings formed an
intermediate group, not differing significantly from their
affected brothers and sisters on the one hand (p values[.12,
all d values = .03–.29) and from controls on the other hand.
This may further suggest that impairments in these cogni-
tive domains are more pronounced in SPX than MPX cases.
Significant differences between SPX affected and unaf-
fected siblings were also found for PIQ (p = .003,
d = .42), face recognition (p = .004, d = .52) and verbal
working memory (p = .039, d = .36), although the latter
effect became non-significant after FDR correction (cor-
rected p = .07). For visual working memory, significant
affected-unaffected sibling contrasts were found for both
SPX (p = .020, d = .39) and MPX (p = .043, d = .33)
families, but, the effect in MPX families did not survive
FDR correction (corrected p = .15). These findings support
the hypothesis that MPX, but not so much SPX, unaffected
siblings share some of the ASD-related cognitive deficits.
Measures not sensitive to SPX-MPX stratification
As describe above, both MPX and SPX unaffected siblings
differed significantly from controls (but not from their
affected brother/sister) on affective prosody. Further, SPX
and MPX probands and unaffected siblings were unim-
paired on visual working memory (p values [.17, all
d values \.21), inhibition (p values [.07, all d values
\.31), and set shifting (p values[.09, all d values\.20),
see Table 3. For means and standard errors of the
untransformed score of SPX and MPX probands, siblings
and controls, see Supplementary Table 2.
Discussion
The main goal of the current study was to examine whether
the cognitive architecture underlying SPX and MPX autism
families is different and useful for parsing etiological
heterogeneity of ASD. This model of different etiologies in
SPX and MPX families is based on evidence from
behaviorally-based and genetic research (Sebat et al. 2007;
Marshall et al. 2008; Freitag 2007; Virkud et al. 2009;
Gerdts et al. 2013). We hypothesized that (a) the different
forms of ASD might result in dissimilar cognitive profiles
in SPX and MPX ASD probands, and (b) unaffected sib-
lings from MPX but not SPX would display (mild) cog-
nitive deficits compared to controls. Our results showed
that directly comparing SPX and MPX ASD cases, no
significant differences were detected and both were asso-
ciated with impairments in VIQ, PIQ, face recognition,
affective prosody recognition, and verbal working memory
compared to healthy controls. However, when compared to
their unaffected siblings, impairments in identification of
facial emotions, VIQ, PIQ, and verbal working memory
were more pronounced in SPX cases than MPX cases.
Unaffected siblings from MPX families had a significantly
lower VIQ (similar to their affected brother/sister) com-
pared to controls, whereas SPX unaffected siblings were
unimpaired in this domain. Both MPX and SPX unaffected
siblings differed significantly from controls on affective
prosody and were unimpaired on the other cognitive
domains. ASD probands and unaffected siblings from MPX
families resembled each other more closely in cognitive
functioning than affected-unaffected siblings from SPX
families.
Results support the hypothesis that a partly different
cognitive architecture may underlie SPX and MPX forms
of ASD, which only becomes evident when contrasting
cognitive performances within families. That is, the direct
comparison between autistic children from SPX and MPX
families revealed very similar cognitive problems, but
when using unaffected siblings as an ideal reference group
(viewed as indexing the ‘full potential’ of children with
ASD had they not developed the disorder and correcting
for shared environmental factors), SPX probands seem to
be more impaired in intelligence, verbal working memory
and emotion recognition than MPX probands, which is not
explained by a more severe ASD phenotype in SPX pro-
bands (i.e., in our sample, SPX and MPX ASD probands
demonstrate equally severe ASD traits, see sample char-
acteristics and Oerlemans et al. 2015). This could indicate
that partly different developmental pathways may result in
a similar phenotype and similar cognitive deficits, a phe-
nomenon that has been referred to in developmental psy-
chopathology as equifinality (Cicchetti and Rogosch 1996).
ASD has often been associated with lower full scale IQ or
intellectual disability (ID) (Charman et al. 2011). One
model that has been proposed for the overlap between ID
and ASD suggests that rare, highly penetrant mutations set
the stage for abnormal developmental trajectories including
ASD, developmental delay and mental retardation (Eapen
2011). Assuming that SPX ASD is more likely than MPX
ASD to develop as a result of such rare (sporadic) genetic
causes, our finding that SPX probands seem to be more
impaired in intelligence than MPX probands and the find-
ing of Davis et al. (2013) that ASD children with low(ered)
intelligence levels more often had SPX than MPX forms of
ASD corroborate this theory.
SPX unaffected siblings were largely unimpaired on
cognitive measures compared to controls, except for
affective prosody, whereas MPX unaffected siblings were
impaired on both affective prosody and VIQ. Several
implications may result from this finding. First of all, it
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suggests that affective prosody is the most sensitive cog-
nitive marker for detecting familial risk for ASD. This
finding is in line with previous analyses using the same
cognitive task in a younger subsample of this cohort
(Oerlemans et al. 2014). The perception of emotional
expressions via affective prosody is highly relevant for the
Table 3 Means and standard errors of the transformed task variables for SPX and MPX probands, their unaffected siblings and normal controls
Controls
(c)
ASD
probands
Unaffected
siblings
Group contrasts Within
family
contrasts
Comparisons between
SPX and MPX family
members
Probands Unaffected
siblings
M (se) Family
type
M (se) M (se) p values* d-
values*
t p p d p d
VIQ .36 (.10) SPX -.37 (.13) .22 (.12) <.001/.392/
< .001
.69/.13/
.59
2.56 .012 .930 .02 .011 .47
MPX -.35 (.10) -.24 (.13) <.001/
< .001/
.409
.68/.57/
.12
PIQ .15 (.10) SPX -.30 (.13) .12 (.12) .008/.841/
.003
.42/.03/
.42
1.02 .311 .418 .15 .848 .05
MPX -.15 (.11) .07 (.14) .045/.620/
.125
.28/.08/
.22
Face recognition .22 (.09) SPX -.42 (.13) .08 (.11) <.001/.315/
.004
.65/.14/
.52
1.29 .203 .149 .26 .893 .02
MPX -.17 (.10) .10 (.14) .004/.471/
.128
.40/.12/
.29
Identification of facial
emotions
.12 (.10) SPX -.30 (.13) .20 (.12) .010/.622/
.002
.40/.07/
.50
2.38 .019 .305 .14 .102 .27
MPX -.12 (.15) -.08 (.15) .097/.254/
.806
.19/.18/
.03
Affective prosody .51 (.11) SPX -.38 (.15) -.13 (.13) <.001/
< .001/
.180
.92/.65/
.25
.88 .379 .282 .20 .812 .02
MPX -.18 (.12) -.11 (.16) <.001/.002/
.706
.70/.65/
.07
Inhibition .12 (.09) SPX -.18 (.13) .05 (.12) .066/.655/
.160
.31/.07/
.23
.53 .596 .623 .10 .941 .01
MPX -.09 (.10) .04 (.14) .137/.639/
.431
.21/
.08.14
Verbal WM .16 (.09) SPX -.29 (.13) .05 (.11) .003/.428/
.039
.46/.11/
.36
.48 .624 .431 .13 .592 .04
MPX -.16 (.11) .09 (.15) .031/.711/
.143
.31/.07/
.24
Visual WM .00 (.09) SPX -.21 (.13) .16 (.11) .171/.274/
.020
.21/.16/
.39
.16 .873 .727 .07 .655 .04
MPX -.14 (.11) .20 (.15) .341/.267/
.043
.14/.20/
.33
Set shifting % errors .09 (.09) SPX -.09 (.13) .08 (.11) .244/.907/
.314
.18/.01/
.18
.21 .832 .736 .06 .958 .02
MPX -.15 (.11) .06 (.15) .088/.854/
.260
.24/.03/
.20
ASD autism spectrum disorders, SPX simplex, MPX multiplex, M mean, se standard error, WM working memory. Significant group contrasts that
survived FDR correction are presented in bold
* p values and effect sizes in terms of Cohen’s d (d values) are presented in the following order: probands versus controls/siblings versus
controls/probands versus siblings. Lower mean scores represent poorer performance
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development of Theory of Mind (ToM), which refers to the
ability to understand other people’s thoughts, beliefs, and
other internal states (Korkmaz 2011). Many believe that
social cognition deficits are central to explaining the dif-
ficulties experienced by people with ASD (Korkmaz 2011;
Baron-Cohen 1995). Our finding that unaffected siblings
(regardless SPX/MPX status) were impaired on affective
prosody, but not on other cognitive domains, might suggest
that impaired social cognition is the primary cognitive
deficit in ASD, resulting from shared (genetic and/or
environmental) risk factors that disrupt the ability to pro-
cess emotional cues in individuals with autism and (to
some extent) their unaffected first-degree relatives. Second,
it suggests that the unaffected siblings from SPX families
are not completely free from cognitive deficits. The finding
is consistent with findings that although de novo genetic
variations most likely play a role in the development of
simplex ASD, they do not fully explain genetic etiology
(Krumm et al. 2013). In other words, also in SPX ASD
families some risks may be shared between family mem-
bers (Klei et al. 2012), and the distinction between MPX
and SPX ASD may reflect variation in the magnitude of
effects rather than qualitative differences between groups.
Third, only a few comparisons between MPX unaffected
siblings and controls reached significance. This finding
clearly contrasts with studies in ADHD that firmly
demonstrate significant impairments on cognitive functions
and brain morphology in first-degree unaffected relatives
who are at risk of the disorder (Allen et al. 2009; Rom-
melse et al. 2011). This does not seem to be due to a simple
lack of power: visual inspection of the data indicate no or
only very minor cognitive impairments on several domains
that are impaired in the MPX probands (face recognition,
PIQ, verbal working memory). This suggests that—in
contrast to ADHD—cognitive factors in ASD may have a
stronger determining effect on the development of the final
phenotype. That is, cognitive problems may be part of the
defining features of ASD, rather than being an endophe-
notypic trait that can be seen in unaffected relatives. An
important exception is affective prosody, suggesting this
domain may be sensitive towards familial risk factors for
ASD.
Some limitations to this study need to be acknowledged
when interpreting the results. First, sample sizes were
moderate; it follows that our study needs replication in
larger samples to fully uncover effects. Second, reproduc-
tive stoppage is a factor in ASD. Stoppage is the phe-
nomenon in which parents who already have a child
affected with ASD may decide to not have more children
after symptoms appear and/or an affected child receives the
diagnosis (Hoffmann et al. 2014). It is difficult to tell if
SPX families would be MPX families if not for stoppage,
especially when the proband is severely affected. The issue
of stoppage also has implications for recurrence risk esti-
mates and birth order studies in ASD (Wood et al. 2014).
Ideally, one would account for stoppage, for example by
only examining families with unaffected siblings born
before the affected probands or by only including infor-
mation from the first ASD case in each family. Due to our
limited sample size, we were unable to do so, but we
believe that insofar this has affected our results, it would
likely lead to an underestimation of potential differences
between SPX and MPX ASD cases. Of note, the family
size of the SPX and MPX families did not differ from each
other and were slightly larger than control families and in
about half of the SPX families an unaffected sibling (29
male, 7 female) was born before the affected child. Third,
boys were overrepresented in both proband groups and in
SPX unaffected siblings, but were underrepresented in
MPX unaffected siblings and controls. This was likely due
to the fact that a) ASD is more frequently diagnosed in
males and b) because the presence of male unaffected
siblings was only required for SPX, but not MPX families.
However, we do not believe that this has affected the
results, since the effect of sex was controlled for in this
study. Fourth, although effort was made to include several
tasks tapping the domains of SC and EF, we were not able
to assess all aspects of these cognitive domains. For
example, fluency, planning and theory of mind were not
assessed here. We cannot rule out the possibility that the
cognitive functions not studied here are sensitive to
familial effects. Fifth, only Dutch participants of European
Caucasian ethnicity were included in our study. This may
limit the generalization of our findings to other ethnic
groups. Also, by focusing on average and high-functioning
ASD, the generalizability of our findings to the broad range
of ASD is limited. Future research should consider
extending these findings to lower-functioning individuals
with ASD—a group that is greatly under-represented in
research studies—which may reveal different SPX-MPX
ratios and more pronounced impairments on the various
cognitive domains. Last, the difficulty with matching non-
ASD IQ levels with ASD IQ levels should be discussed.
Often, studies match cases and controls on mental age or
IQ but given that IQ is inherently confounded with ASD, it
cannot be fully separated from the effects of the condition
(Jarrold and Brock 2004; Dennis et al. 2009). Matching IQ
to controls in children with ASD may create unrepresen-
tative groups, with either the ASD group having higher IQs
than the population with the disorder, or the control group
having IQs below normal expectations (Dennis et al. 2009).
The authors suggest that instead, controlling for sociode-
mographic characteristics may be desirable. Given that
estimated verbal and performance IQ (separately) were
outcome measures in our study, we did not match on total
IQ, except from the inclusion criterion of IQ C 70 for all
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participants. Sample characteristics reveal that IQ distri-
butions were highly similar for affected and unaffected
siblings and controls (albeit higher mean IQ for controls
than affected children) and parental educational levels were
largely similar across groups, indicating that the controls
may be an adequate comparison group. Differences in age
and sex across groups were controlled for in the analyses.
All in all, results suggest that some differences between
SPX and MPX forms of ASD exist, which becomes evident
when contrasting cognitive performances within families.
These findings may help parse etiological heterogeneity of
ASD by stratifying ASD families into families with
stronger versus weaker familial aggregation of ASD-re-
lated cognitive deficits.
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